News & Analysis on Pharmaceutical Technology & Manufacturing
Dr. Nick Glover
By Dan Stanton
- Last updated on
To San Diego now, and MEI Pharma has added Dr. Nick Glover to its Board of Directors.
Most recently President and Chief Executive Officer of YM BioSciences - an oncology drug development company acquired by Gilead Sciences for $510 million earlier this year – “Dr. Glover is a natural fit to round out [MEI Pharma’s] Board of Directors, adding a wealth of relevant strategic and operational knowledge,” said CEO Dr. Daniel Gold.